δ-Hemolysin features a small, amphipathic peptide that readily adopts helical conformations in lipid-mimetic systems. Hydrophobic residues drive membrane association, while polar units fine-tune structural transitions. Researchers examine its dynamic behavior and binding interactions. Use spans natural-toxin modeling, biophysical studies, and membrane-active peptide research.
CAT No: R2518
CAS No:74838-20-3
Synonyms/Alias:delta-Hemolysin;delta-Lysin;Hld protein;Staph delta-hemolysin;delta-Hemolysin, staph aureus;Staphylococcal delta-haemolysin;Hld protein, Staphylococcus aureus;delta Hemolysin, staphylococcus aureus;Delta hemolysin protein, Staphylococcus aureus;74838-20-3;delta-Hemolysin (Staphylococcus aureus strain 186X);DA-52429;
1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
2. High fat diet and GLP-1 drugs induce pancreatic injury in mice
3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.